A detailed history of Comerica Bank transactions in Axonics, Inc. stock. As of the latest transaction made, Comerica Bank holds 343 shares of AXNX stock, worth $24,346. This represents 0.0% of its overall portfolio holdings.

Number of Shares
343
Previous 130 163.85%
Holding current value
$24,346
Previous $8,000 187.5%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.3 - $69.67 $14,334 - $14,839
213 Added 163.85%
343 $23,000
Q2 2024

Aug 15, 2024

BUY
$66.47 - $69.65 $5,317 - $5,572
80 Added 160.0%
130 $8,000
Q1 2024

May 15, 2024

SELL
$56.67 - $69.36 $77,411 - $94,745
-1,366 Reduced 96.47%
50 $3,000
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $38,664 - $49,916
783 Added 123.7%
1,416 $88,000
Q3 2023

Nov 21, 2023

SELL
$48.64 - $62.51 $455,659 - $585,593
-9,368 Reduced 93.67%
633 $35,000
Q2 2023

Aug 22, 2023

BUY
$47.99 - $60.21 $479,947 - $602,160
10,001 New
10,001 $0

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.